Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01943903 · ClinicalTrials.gov registry record
The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)
A clinical trial, sponsored by HeartFlow.
- Completed
- Registry status
- 584
- Enrollment target
NCT01943903: Completed study, sponsored by HeartFlow.
NCT01943903 is a clinical trial that has completed, run by HeartFlow. The registered enrollment target is 584 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01943903 has completed, sponsored by HeartFlow.
- COMPLETED
- Registry status
- 584 participants
- Enrollment target
Study Summary
The objective of the PLATFORM Study is to compare clinical outcomes, resource utilization, and quality of life (QOL) of FFRCT-guided evaluation versus standard practice evaluation in patients with suspected CAD in order to further inform patients, health care providers, and other stakeholders about which technologies are most effective and efficient in the diagnosis of CAD
Primary Outcome
The primary endpoint of the PLATFORM Study is 90 day (+30/-15 days) rate of coronary angiogram showing no stenosis \> 50% in a vessel \> 2.0 mm by Quantitative Coronary Angiography (QCA), or no invasively-measured FFR \< 0.80 in a segment distal to a stenosis in a vessel \> 2.0 mm by QCA between Cohort 1 and 2.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 584 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-12 |
What the finished NCT01943903 record still lists
NCT01943903 is an observational study that tracks outcomes without assigning an intervention. The registered 584 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01943903 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01943903 about?
NCT01943903 is a clinical study titled "The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)". The objective of the PLATFORM Study is to compare clinical outcomes, resource utilization, and quality of life (QOL) of FFRCT-guided evaluation versus standard practice evaluation in patients with suspected CAD in order to further inform patients, health care providers, and other stakeholders about ...
What is the current status of trial NCT01943903?
This trial is currently completed. The enrollment target is 584 participants. The study started on 2013-09. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01943903?
This trial is sponsored by HeartFlow, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03840083 · 584 participants · NA
Sleep-dependent Learning in Aging
- NCT04984291 · 584 participants · NA
Zimmer Biomet Shoulder Arthroplasty PMCF
- NCT05983757 · 584 participants · NA
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
- NCT06569290 · 584 participants · NA
Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia